Sanofi pays up to USD 1bn for new multiple myeloma therapy
![Photo: CHARLES PLATIAU/Reuters / X00217](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13118641.ece/ALTERNATES/schema-16_9/doc7gkbrjp8ai8ivdfb8ij.jpg)
Sanofi is paying an undisclosed amount to forge a new license agreement with Eureka Therapeutics. However, the value of the deal might reach USD 1bn in subsequent milestone payments, according to a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.